Albert Juan Fuglsang-Madsen (A E Hansen, Anders E Hansen)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Venues

Science advances

Antimicrobial agents and chemotherapy

Small (Weinheim an der Bergstrasse, Germany)

ACS nano

DTU Nanotech

This page only lists publications with an associated author ORCID identifier.

Affiliation History

DTU Nanotech Jan 03 2013

Denmark

Senior Researcher, DVM, PhD :: Colloid and Biologic Interfaces

Publications

Albert Juan Fuglsang-Madsen, Nicole Lind Henriksen, Elizabeth Serrano Chávez, Lasse Andersson Kvich, Julie Knippel Melsted Birch, Katrine Top Hartmann, Thomas Eriksen, Thomas Bjarnsholt, Hans Gottlieb, Thomas Lars Andresen, Louise Kruse Jensen, Jonas Rosager Henriksen, Anders Elias Hansen
Eradication of Staphylococcus aureus in Implant-Associated Osteomyelitis by an Injectable in situ-Forming Depot Antibiotics Delivery System. The Journal of infectious diseases (2024)
Nicole Lind Henriksen, Elizabeth Serrano-Chávez, Albert Fuglsang-Madsen, Louise K Jensen, Hans Gottlieb, Mats Bue, Thomas L Andresen, Jonas R Henriksen, Albert Juan Fuglsang-Madsen
Gentamicin and clindamycin antibiotic-eluting depot technology eradicates S. aureus in an implant-associated osteomyelitis pig model without systemic antibiotics. Antimicrobial agents and chemotherapy (2024)
Rasmus Münter, Camilla Stavnsbjerg, Esben Christensen, Mikkel E Thomsen, Allan Stensballe, Albert Juan Fuglsang-Madsen, Ladan Parhamifar, Kasper Kristensen, Jens B Simonsen, Jannik Bruun Larsen, Thomas Lars Andresen
Unravelling Heterogeneities in Complement and Antibody Opsonization of Individual Liposomes as a Function of Surface Architecture. Small (Weinheim an der Bergstrasse, Germany) 18 (14) (2022)
Lars Ringgaard Petersen, F Melander, R Eliasen, J R Henriksen, Rasmus I Jølck, T B Engel, M Bak, Frederikke P Fliedner, Kasper Kristensen, Dennis Ringkjøbing Elema, Andreas Kjaer, Albert Juan Fuglsang-Madsen, Thomas Lars Andresen
Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy. Science advances 6 (36) (2020)
Albert Juan Fuglsang-Madsen, Jonas R Henriksen, Rasmus I Jølck, Frederikke P Fliedner, Linda M Bruun, Jonas Scherman, Andreas I Jensen, Per Munck Af Rosenschöld, Lilah Moorman, Sorel Kurbegovic, Steen R de Blanck, Klaus R Larsen, Paul F Clementsen, Anders N Christensen, Mads Hartvig Clausen, Wenbo Wang, Paul Joseph Kempen, Merete Christensen, Niels-Erik Viby, Gitte Fredberg Persson, Rasmus Larsen, Knut Conradsen, Fintan J McEvoy, Andreas Kjaer, Thomas Eriksen, Thomas Lars Andresen
Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention. Science advances 6 (34) (2020)
Betina Børresen, Jonas R Henriksen, Gael Clergeaud, Jennifer S Jørgensen, Fredrik Melander, Dennis R Elema, Janos Szebeni, Svend Aage Engelholm, Annemarie T Kristensen, Andreas Kjær, Thomas L Andresen, Albert Juan Fuglsang-Madsen
Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics. ACS nano 12 (11) (2018)

Albert Juan Fuglsang-Madsen.css-eqlu8i{font-size:small;padding-left:4px;} (A E Hansen, Anders E Hansen)

Publication Activity (10 Years)

Top Topics

Top Venues

Albert Juan Fuglsang-Madsen (A E Hansen, Anders E Hansen)